Winton Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-17,230
Closed -$1.34M 419
2016
Q2
$1.34M Sell
17,230
-917,162
-98% -$65.4M 0.02% 270
2016
Q1
$51.4M Buy
934,392
+514,281
+122% +$28M 0.56% 55
2015
Q4
$25.9M Buy
420,111
+372,908
+790% +$23.5M 0.23% 169
2015
Q3
$2.98M Sell
47,203
-136,102
-74% -$9.71M 0.02% 346
2015
Q2
$13.4M Buy
183,305
+58,187
+47% +$4.2M 0.12% 247
2015
Q1
$8.18M Sell
125,118
-130,325
-51% -$8.67M 0.07% 312
2014
Q4
$16.6M Sell
255,443
-223,160
-47% -$14.4M 0.21% 186
2014
Q3
$28.8M Sell
478,603
-275,996
-37% -$18M 0.21% 202
2014
Q2
$52.3M Buy
+754,599
New +$48.9M 0.36% 90

Other funds holding STJ

Winton Group's STJ Position: Q3 2016 in Review

Winton Group sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 17,230 shares — an estimated $1.34M sold.

Winton Group first reported a position in STJ in Q2 2014 and held it in 9 quarters. The position peaked at $52.3M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Winton Group reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Winton Group sold 17,230 St Jude Medical shares in Q3 2016, an estimated $1.34M.
  • Winton Group first reported a position in St Jude Medical in Q2 2014 and held it in 9 quarters.
  • Winton Group's St Jude Medical position peaked at $52.3M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Winton Group's 13F filing for Q3 2016, filed 8 Nov 2016.